Satisfaction, Safety and Cost of the Treatment for Multiple Sclerosis Relapse with Intravenous versus Oral Methylprednisolone

Introduction: Relapse is a clinical indication of MS activity. Treatment with corticosteroids is recommended for anti-inflammatory, immunosuppressive effects and reduction in the duration and intensity of symptoms. The dosage of intravenous methylprednisolone (ivMP) is 500-1000 mg daily and that of...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Montserrat Gonzalez-Platas, Pérez Martín Maria Yaiza, Espinosa Bueno Inmaculada, González Perera Itamar, Díaz Stier Noemi, Eguía del Río Pablo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Mashhad University of Medical Sciences 2018-10-01
coleção:	Patient Safety and Quality Improvement Journal
Assuntos:	Intravenous methylprednisolone Multiple sclerosis relapse Oral methylprednisolone Satisfaction Treatment Costs
Acesso em linha:	http://psj.mums.ac.ir/article_11702_d41d8cd98f00b204e9800998ecf8427e.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!